RightFit
RecruitingNot applicable

Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Wearing a device

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests morning bright light therapy using a Re-Timer® wearable device for depression after childbirth. It is for people who gave birth within the past 6 months and have signs of depression. The study looks at how practical the treatment is, how people feel about using it, and how it could fit into care.

The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Gave birth within the past 6 months.
  • Score above 10 on the EPDS, a questionnaire that checks for depression after childbirth.

Who can't join

  • Have a substance use disorder now or had one in the past year.
  • Have ever had bipolar disorder or a psychotic disorder, which can affect a person's sense of what is real.
  • Currently intend to end your life.
  • Have disease in the retina, the light-sensing part of the eye, or have had eye surgery.
  • Take medicine that makes you more sensitive to light.
  • Have untreated breathing problems during sleep, untreated restless legs syndrome (an urge to move your legs), or narcolepsy (a condition that causes extreme sleepiness).
  • Started talk therapy or mental health medicine, or changed its dose, in the past month. Talk therapy started at least 4 weeks ago and medicine at the same dose for at least 4 weeks are allowed.
  • Have a health condition that makes morning bright light therapy unsafe, such as epilepsy or seizures.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. ≤ 6 months postpartum 2. EPDS score \>10 Exclusion Criteria: 1. Current or past-year substance use disorder 2. Lifetime history of bipolar disorder or psychotic disorder 3. Active suicidal intent 4. Retinal pathology or history of eye surgery 5. Current use of photosensitizing medications 6. Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy 7. Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted) 8. Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)

Study sites (1)

MI